International Journal of Endocrinology and Metabolism
Research Institute for Endocrine Sciences
Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
Efficacy of Orlistat on Cardiometabolic Indices in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A GRADE-Assessed Systematic Review and Meta-Analysis of RCTs
Current Therapeutic Research Clinical and Experimental
June 2026
Karimi M.
Open Access
Long-Term Effects of Orlistat on Lipid Metabolism and Anthropometric Indices: A Meta-Analysis of Clinical Trials
Journal of Obesity
2026
Khodadadiyan A.
Open Access
Combined Potential of Orlistat with Natural Sources and Their Bioactive Compounds Against Obesity: A Review
Molecules
June 2025
Uuh Narvaez J.J.
Open Access
Postprandial Metabolic Mesponses to High-fat Feeding in Healthy Adults Following Ingestion of Oolong Tea–Derived Polymerized Polyphenols: A Randomized, Double-blinded, Placebo-controlled Crossover Study
American Journal of Clinical Nutrition
July 2023
Perkin O.J.
Open Access
Effects of oral contraceptives plus orlistat in patients with polycystic ovary syndrome and overweight/obesity: A meta-analysis
Journal of Obstetrics and Gynaecology Research
June 2022
Chen Z.
Postprandial hypertriglyceridaemia revisited in the era of non-fasting lipid profile testing: A 2019 expert panel statement, narrative review
Current Vascular Pharmacology
2019
Kolovou G.D.
Efficacy of orlistat in non-alcoholic fatty liver disease: A systematic review and meta-analysis
Biomedical Reports
July 2018
Wang H.
Open Access
Effect of orlistat or metformin in overweight and obese polycystic ovary syndrome patients with insulin resistance
Gynecological Endocrinology
4 May 2018
Song J.
Potential Drug Combinations to Reduce Cardiovascular Disease Burden in Diabetes
Trends in Pharmacological Sciences
1 March 2016
Pillarisetti S.
The effect of orlistat on postprandial hypertriglyceridemia by oral fat loading test. A systematic review
Nutricion Hospitalaria
2016
Rodríguez-Valle A.
Open Access
Preventive action of orlistat on cardiovascular risks in young obesity patients
Cardiovascular Therapy and Prevention Russian Federation
2015
Korneeva E.V.
Open Access
Benefit-risk assessment of orlistat in the treatment of obesity
Drug Safety
August 2014
Sumithran P.
All Open Access, Green
Postprandial peaking and plateauing of triglycerides and VLDL in patients with underlying cardiovascular diseases despite treatment
International Journal of Endocrinology and Metabolism
2012
Samson C.E.
Open Access